Followers | 9843 |
Posts | 260031 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Thursday, November 01, 2018 5:46:41 PM
Link to Video - click here to watch the technical chart video
Recent ARGX News
- argenx to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 11/05/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/31/2024 12:15:39 PM
- argenx Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 10/31/2024 06:00:00 AM
- argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024 • GlobeNewswire Inc. • 10/24/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/15/2024 12:14:04 PM
- argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions • GlobeNewswire Inc. • 10/15/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/19/2024 10:06:23 AM
- argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy • GlobeNewswire Inc. • 09/19/2024 05:00:00 AM
- argenx to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/25/2024 10:01:40 AM
- argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update • GlobeNewswire Inc. • 07/25/2024 05:00:00 AM
- argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 • GlobeNewswire Inc. • 07/18/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/16/2024 09:22:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/16/2024 08:03:55 PM
- argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China • GlobeNewswire Inc. • 07/16/2024 04:30:00 AM
- Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China • Business Wire • 07/16/2024 04:15:00 AM
- argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting • GlobeNewswire Inc. • 06/25/2024 08:30:00 PM
- argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy • GlobeNewswire Inc. • 06/21/2024 08:50:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2024 10:05:43 AM
- argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024 • GlobeNewswire Inc. • 06/17/2024 05:00:00 AM
- argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/09/2024 11:06:00 AM
- argenx Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 10:15:25 AM
- argenx announces results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 05/07/2024 09:30:00 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM